Cargando…
Acute cognitive effects of single-dose intravenous ketamine in major depressive and posttraumatic stress disorder
Intravenous (IV) subanesthetic doses of ketamine have been shown to reduce psychiatric distress in both major depressive (MDD) and posttraumatic stress disorder (PTSD). However, the effect of ketamine on cognitive function in these disorders is not well understood. To address this gap, we examined t...
Autores principales: | Davis, Margaret T., DellaGiogia, Nicole, Maruff, Paul, Pietrzak, Robert H., Esterlis, Irina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032778/ https://www.ncbi.nlm.nih.gov/pubmed/33833217 http://dx.doi.org/10.1038/s41398-021-01327-5 |
Ejemplares similares
-
Differential Role of mGluR5 in Cognitive Processes in Posttraumatic Stress Disorder and Major Depression
por: Esterlis, Irina, et al.
Publicado: (2022) -
Nicotine Use and Metabotropic Glutamate Receptor 5 in Individuals
With Major Depressive and Posttraumatic Stress Disorders
por: Baldassarri, Stephen R., et al.
Publicado: (2023) -
Characterization of Comorbid Posttraumatic Stress Disorder and Major Depressive Disorder Using Ketamine as an Experimental Medicine Probe (†)
por: Albott, C. Sophia, et al.
Publicado: (2021) -
Baseline Plasma BDNF Levelsare Associated with Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Major Depressive Disorder
por: Zheng, Wei, et al.
Publicado: (2023) -
Neurobiology of Chronic Stress-Related Psychiatric Disorders: Evidence from
Molecular Imaging Studies
por: Davis, Margaret T., et al.
Publicado: (2017)